Establishment of the MID-NET® medical information database network as a reliable and valuable database for drug safety assessments in Japan.

Mitsune YamaguchiSatomi InomataSayoko HaradaYu MatsuzakiMaiko KawaguchiMayuko UjibeMari KishibaYoshiaki FujimuraMichio KimuraKoichiro MurataNaoki NakashimaMasaharu NakayamaKazuhiko OheTakao OriiEizaburo SueokaTakahiro SuzukiHideto YokoiFumitaka TakahashiYoshiaki Uyama

Published in: Pharmacoepidemiology and drug safety (2019)

MID-NET® is expected to be a major data source for drug safety assessments in Japan. Experiences and best practices established in MID-NET® may provide a model for the future development of similar database networks.

Keyphrases

adverse drug
healthcare
electronic health record
primary care
mental health
emergency department
machine learning
deep learning
artificial intelligence